Nucleosides and nucleotides excl. reverse transcriptase inhibitors

Ganciclovir Sodium

Approved 20 Jun 2019InjectionInjectable

The FDA lists this product in 8 strengths and forms.

Official labelAsk Osler about it

Composition

Active ingredients: GANCICLOVIR SODIUM EQ 500MG BASE/VIAL

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA212001.

Open Drugs@FDA

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Ganciclovir Sodium
Drug class: Nucleosides and nucleotides excl. reverse transcriptase inhibitors, Antivirals
Group: Antivirals
Route: Injection
Dosage form: Injectable
Applicant: Custopharm Inc
Status: Discontinued
FDA approval: 20 Jun 2019
Application: ANDA212001-001
RxCUI: 82131